Elliptic Laboratories ASA (OSL:ELABS)

Norway flag Norway · Delayed Price · Currency is NOK
3.000
-0.010 (-0.33%)
Apr 28, 2026, 4:25 PM CET
-67.81%
Market Cap 379.01M
Revenue (ttm) 101.31M
Net Income (ttm) -138.17M
Shares Out 126.34M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE 6.19
Dividend n/a
Ex-Dividend Date n/a
Volume 110,237
Average Volume 401,269
Open 2.800
Previous Close 3.010
Day's Range 2.800 - 3.050
52-Week Range 2.540 - 14.440
Beta 0.81
RSI 44.84
Earnings Date Apr 28, 2026

About Elliptic Laboratories ASA

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on devices and to allow intuitive responses based on natural human interaction; AI Virtual Proximity Sensor that enables exquisite full-screen devices; a... [Read more]

Sector Technology
Founded 2006
Employees 88
Stock Exchange Oslo Børs
Ticker Symbol ELABS
Full Company Profile

Financial Performance

Financial Statements

News

Elliptic Laboratories ASA Earnings Call Transcript: Q4 2025

Revenue for 2025 declined to $102.7 million due to revised milestone recognition, with a net loss of $138.2 million after derecognition of deferred tax assets. Shipment volumes and model launches increased, and strategic focus is on cost reduction, expanding into new verticals, and productizing the AI platform.

2 months ago - Transcripts

Elliptic Laboratories ASA Earnings Call Transcript: Q3 2025

Q3 revenue rose 50% year-over-year to NOK 42.3 million, driven by milestone laptop contracts, with EBITDA up to NOK 12.7 million. High shipment volumes and a growing install base set the stage for future pay-as-you-go revenue, while a strategic review is underway to refine commercial priorities.

5 months ago - Transcripts

Elliptic Laboratories ASA Earnings Call Transcript: Q2 2025

Solid commercial progress in H1 2025 with major new contracts and strong device launches, despite a one-time revenue deferral impacting Q2. Majority of new contract revenue to be recognized in Q3, supporting double-digit growth for 2025.

8 months ago - Transcripts

Elliptic Laboratories ASA Earnings Call Transcript: Q1 2025

Q1 2025 saw 20% revenue growth and improved EBITDA, with strong cash flow and a robust balance sheet. Rapid expansion in both laptop and smartphone segments, new product launches, and deepened partnerships position the company for continued growth.

1 year ago - Transcripts

Elliptic Laboratories ASA Earnings Call Transcript: Q4 2024

Revenue nearly doubled in 2024, driven by strong smartphone and laptop launches, with EBITDA margin improving and cash flow strengthening. Growth is expected to continue in 2025, supported by new contracts, product innovation, and favorable market trends.

1 year ago - Transcripts

Elliptic Laboratories ASA Earnings Call Transcript: Q3 2024

Q3 2024 saw 29% year-over-year revenue growth and a 43% increase year-to-date, with positive EBITDA and strong market expansion into PC accessories and AI-driven solutions. Improved contract terms are expected to enhance cash flow in Q4.

1 year ago - Transcripts

Elliptic Laboratories ASA Transcript: Investor Update

A major AI software platform update introduces the Virtual Seamless Sensor, enabling cross-device interoperability and deeper integration with Lenovo, including the launch of Smart Share. The company is scaling rapidly in the laptop market, increasing pricing power, and expects recurring revenue growth as more models are launched.

1 year ago - Transcripts

Elliptic Laboratories ASA Earnings Call Transcript: Q2 2024

Strong Q2 momentum in the PC laptop market with two new contracts, including a first consumer segment win. Revenue grew 51% year-to-date, EBITDA turned positive, and the company maintains a robust cash position. AI-capable device demand and market recovery support a positive outlook.

1 year ago - Transcripts